The presence of CD4+ and CD8+ T cells may indicate a protection against COVID-19, considering that SARS-CoV-2 patients with SARS-CoV-2 vaccine have the so-called hybrid immunity (HI) (infection plus vaccination), and experience reduced severity and fewer hospitalizations upon reinfection [48]. The gene discussed is CD4; the disease is COVID-19.